Literature DB >> 11678335

Assessment of differential expression of oncogenes in gastric adenocarcinoma by fluorescent multiplex RT-PCR assay.

U Rajcevic1, R Juvan, B Gazvoda, S Repse, R Komel.   

Abstract

We screened samples of tumour and peripheral normal tissue for differential expression of oncogenes by using an approach of detecting the differences in expression of a number of oncogenes simultaneously. Total RNA was isolated from 29 pairs of normal and tumour tissue samples from patients with gastric adenocarcinoma. Seven pairs of primers for oncogenes most probably associated with the process of carcinogenesis in stomach including cyclin E, c-erbB-3, HGR, c-met, TDGF/cripto, FGF-4, and EGF were used for the construction of fluorescent multiplex RT-PCR. Sense primers were 5' end-labelled with a fluorescent dye. 5-7 gastric oncogenes were simultaneously analysed for overexpression. Multiplex reverse transcription with a set of unlabeled primers was followed by a PCR reaction by adding the corresponding set of fluorescent labelled PCR-primers. Expression of oncogenes was compared to GAPDH internal standard. Multiplex fluorescent RT-PCR results were analysed by capillary electrophoresis on ABI-PRISM 310 Genetic Analyzer. Differential expression of oncogene mRNAs in tumour and normal tissue was assessed by comparison of oncogene/GAPDH ratios in tumours and their peripheral normal mucosa. Our results show, that in most patients, comparing to normal tissue, we could estimate overexpression of at least one oncogene in a sample.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678335     DOI: 10.1007/s004240100020

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  2 in total

Review 1.  MET pathway as a therapeutic target.

Authors:  Eric S Kim; Ravi Salgia
Journal:  J Thorac Oncol       Date:  2009-04       Impact factor: 15.609

2.  Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Authors:  Julia Kneissl; Anja Hartmann; Nicole Pfarr; Franziska Erlmeier; Thomas Lorber; Simone Keller; Gwen Zwingenberger; Wilko Weichert; Birgit Luber
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-08       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.